Literature DB >> 15103511

Common variable immunodeficiency: a review.

M Di Renzo1, A L Pasqui, A Auteri.   

Abstract

Common variable immunodeficiency (CVID) is the commonest symptomatic primary antibody deficiency syndrome. The predominant manifestation is hypogammaglobulinemia. CVID is characterized by recurrent bacterial infections, especially of the upper and lower respiratory airways, and is also associated with an increased incidence of autoimmune and neoplastic disorders. Most patients are diagnosed as adults and delay in the recognition of the disease is common. Several T and B cell defects have been described, although the underlying cause is still unknown.

Entities:  

Mesh:

Year:  2004        PMID: 15103511     DOI: 10.1007/s10238-004-0027-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  21 in total

1.  NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Authors:  K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID).

Authors:  Kaushang Gandhi; Purvi Parikh; Wilbert S Aronow; Harit Desai; Harshad Amin; Mala Sharma; Arye Rubinstein
Journal:  J Gastrointest Cancer       Date:  2010-12

3.  The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.

Authors:  John J Lee; Ingrid Rauter; Lilit Garibyan; Esra Ozcan; Tatyana Sannikova; Stacey R Dillon; Anthony C Cruz; Richard M Siegel; Richard Bram; Haifa Jabara; Raif S Geha
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

4.  TACI mutations and disease susceptibility in patients with common variable immunodeficiency.

Authors:  A E J Poodt; G J A Driessen; A de Klein; J J M van Dongen; M van der Burg; E de Vries
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

6.  Mannose-binding lectin polymorphisms in common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Farshad Foroughi; Nima Rezaei; Saeid Dianat; Ghasem Solgi; Ali Akbar Amirzargar
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

7.  Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.

Authors:  Nima Rezaei; Asghar Aghamohammadi; Seyed Davar Siadat; Mostafa Moin; Zahra Pourpak; Mehdi Nejati; Hojat Ahmadi; Samineh Kamali; Dariush Norouzian; Bahman Tabaraei; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

Review 8.  Therapeutic management of primary immunodeficiency in older patients.

Authors:  Nisha Verma; Anthony Thaventhiran; Benjamin Gathmann; James Thaventhiran; Bodo Grimbacher
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 9.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

10.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.